Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jun 11;7(3):234-46.
doi: 10.2203/dose-response.08-026.Prieto.

Amifostine (WR2721) confers DNA protection to in vivo cisplatin-treated murine peripheral blood leukocytes

E A Prieto González  1 , A G Fuchs, González S Sánchez
Affiliations

Amifostine (WR2721) confers DNA protection to in vivo cisplatin-treated murine peripheral blood leukocytes

E A Prieto González et al. Dose Response. .

Abstract

Amifostine [S-2-3-aminopropyl amino ethyl phosphorotioic acid], a modulator agent for antineoplastic drugs involved in free radicals generation has given controversial results in cisplatin treated leukocytes in vitro. We have evaluated the amifostine protection over leukocytes in vivo, using comet assay. Groups of five OF1 male mice were given one of three doses of amifostine (56, 105 and 200 mg/Kg) after a cisplatin single injection (10 mg/Kg). Serum malonyldialdehyde levels, catalase and superoxide dismutase activity were also evaluated. Amifostine showed significant DNA protection (p< 0.01) at the two lower doses evaluated. Malonyldialdehyde decreased in all amifostine treatments with respect to cisplatin while antioxidant enzyme activities remained unchanged. However, DNA migration increased with the highest amifostine dose; in fact highest dose of amifostine did no protect damage caused by cisplatin this result have implications on amifostine treatment schedules in clinical practice.

Keywords: DNA damage; amifostine; antioxidant; cisplatin; comet assay; lymphocytes.

PubMed Disclaimer

References

    1. Aebi H. Catalase in vitro. Methods Enzimol. 1984;105:121–126. - PubMed
    1. Anderson D, Yu TW, Phillips BJ, Scheneider P. The effect of various antioxidants and other modifying agents on oxygen radicals generated DNA damage in human lymphocytes in the comet assay. Mutat Res. 1994;307:261–271. - PubMed
    1. Atalay H, Aybek H, Koseoglu M, Demir S, Erbay H, Bolaman AZ, Avci A. The effects of amifostine and dexamethasone on brain tissue lipid peroxidation during oxygen treatment of carbon monoxide-poisoned rats. Adv Ther. 2006;2:332–41. - PubMed
    1. Bergström P, Johnsson A, Bergenheim T, Henriksson R. Effects of amifostine on cisplatin induced DNA adduct formation and toxicity in malignant glioma and normal tissues in rat. J Neurooncol Mar. 1999;1:13–21. - PubMed
    1. Bhattacharya R, Lakshmana Rao PV, Pant SC, Kumar P, Tulsawani RK, Pathak U, Kulkarni A, Vijayaraghavan R. Protective Effects of Amifostine and Its Analogues on Sulfur Mustard Toxicity in Vitro and in Vivo. Toxicol and Applied Pharmacol. 2001;176:24–33. - PubMed

LinkOut - more resources